The new long-acting injectable for maintenance treatment of schizophrenia: what is the clinical value of aripiprazole 2-month ready-to-use 960 mg?

• Cecilio Álamo ^[1] ; Ana Catalán ^[2] ; David Fraguas ^[4] ; Francisco Gotor ^[5] ; Javier Labad ^[6] ; Carlos Parro Torres ^[7] ; Víctor Pérez ^[3] ; Pilar Sierra ^[8]
  1. [1] Universidad de Alcalá

     Universidad de Alcalá

     Alcalá de Henares, España

     
  2. [2] Universidad del País Vasco/Euskal Herriko Unibertsitatea

     Universidad del País Vasco/Euskal Herriko Unibertsitatea

     Leioa, España

     
  3. [3] Universitat Autònoma de Barcelona

     Universitat Autònoma de Barcelona

     Barcelona, España

     
  4. [4] Institute of Psychiatry and Mental Health, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), School of Medicine, Universidad Complutense, Madrid, Spain
  5. [5] Psychiatry Department, School of Medicine, University Hospital Virgen del Rocio, Seville, Spain
  6. [6] Department of Mental Health and Addictions, Consorci Sanitari del Maresme, Mataró, Spain
  7. [7] Institute of Psychiatry and Mental Health, Gregorio Marañón University General Hospital, Madrid, Spain
  8. [8] Department of Psychiatry and Clinical Psychology, La Fe University and Polytechnic Hospital, Valencia, Spain

  Mostrar afiliaciones +
• Localización: European journal of psychiatry, ISSN 0213-6163, Vol. 38, Nº 3, 2024
• Idioma: inglés
• DOI: 10.1016/j.ejpsy.2024.100260
• Enlaces
  • Texto completo